Business Context and Reporting Period
Jacobs Solutions Inc. filed its fiscal 2023 Form 10-K for the year ended September 29, 2023. The company is a global professional services provider with approximately 60,000 employees, delivering engineering, consulting, technical, scientific, construction-management and technology-enabled services to government and commercial customers.
Fiscal 2023 operating segments were Critical Mission Solutions (CMS), People & Places Solutions (P&PS), Divergent Solutions (DVS) and the 65%-owned PA Consulting business. The filing was signed November 21, 2023. It is an annual filing rather than a standalone 2023 fourth-quarter report; quarterly results are not separately provided in the supplied text.
Key Financial Metrics
| Metric | Fiscal 2023 | Fiscal 2022 | Change |
|---|---|---|---|
| Revenue | $16.35 billion | $14.92 billion | Up 9.6% |
| Gross profit | $3.47 billion | $3.33 billion | Up 4.4% |
| Gross margin | 21.2% | 22.3% | Down 110 basis points |
| Operating profit | $1.08 billion | $917.9 million | Up $157.4 million |
| Net earnings attributable to Jacobs | $665.8 million | $644.0 million | Up 3.4% |
| Diluted EPS | $5.30 | $4.98 | Up 6.4% |
| Net cash from operations | $974.8 million | $474.7 million | Up $500.1 million |
| Capital expenditures | $137.5 million | $127.6 million | Up $9.9 million |
| Backlog | $29.1 billion | $27.9 billion | Up $1.2 billion |
Operating profit margin was approximately 6.6% in fiscal 2023 versus 6.2% in fiscal 2022. Net earnings attributable to Jacobs represented approximately 4.1% of revenue, compared with 4.3% in the prior year.
- Revenue growth was led by P&PS, which increased 11.9% to $9.55 billion, and CMS, which increased 7.2% to $4.69 billion. DVS revenue increased 6.1% to $946.9 million, while PA Consulting increased 3.5% to $1.16 billion.
- Segment operating profit increased 16.1% at P&PS, 6.4% at CMS and 21.0% at DVS. PA Consulting operating profit increased 2.1%.
- Income from continuing operations attributable to Jacobs was $666.6 million, or $5.31 diluted EPS. Discontinued operations generated a loss of $0.8 million.
- The effective tax rate increased to 21.4% from 18.4%, mainly because fiscal 2023 had fewer favorable tax adjustments than fiscal 2022.
- Cash and cash equivalents were $926.6 million at year-end, down from $1.14 billion. Cash flow benefited from the absence of the prior-year cash payment related to the Legacy CH2M Matter and improved working capital.
- Cash used in financing was $1.09 billion, including $616.6 million of net debt repayments, $265.7 million of share repurchases and $128.4 million of shareholder dividends.
- Total debt was approximately $2.87 billion, consisting of $61.4 million of short-term debt and $2.81 billion of long-term debt. The company had $2.24 billion of available capacity under its $2.25 billion revolving credit facility and was in compliance with debt covenants.
- Variable-rate borrowings and term-loan facilities totaled approximately $1.78 billion at year-end. Interest-rate swaps covered $769.1 million of notional debt, leaving approximately $1.01 billion of principal exposed to variable rates.
Material Changes Versus the Prior Comparable Period
- Revenue and operating profit improved, particularly in P&PS, CMS nuclear remediation and government programs, DVS software licensing and new programs, and PA Consulting’s defense, public services and energy businesses.
- Gross margin declined because of project mix, higher personnel costs and lower utilization trends, particularly at PA Consulting, partly offset by new program starts.
- Net interest expense increased to $142.1 million from $95.8 million because of higher interest rates, despite lower average debt balances late in the year.
- Fiscal 2023 included $133.0 million of restructuring and other charges, including CMS separation activities, real-estate impairments and PA Consulting restructuring. Fiscal 2022 included the $91.3 million pre-tax incremental settlement charge for the Legacy CH2M Matter.
- The company issued $500 million of 5.90% bonds due 2033 and $600 million of 6.35% bonds due 2028, while repaying or refinancing other debt. The former Senior Notes were fully repaid during fiscal 2023.
- Share repurchases totaled $265.7 million, and the company had $874.8 million remaining under its $1.0 billion 2023 repurchase authorization at year-end. Quarterly dividends increased from $0.23 per share to $0.26 per share beginning in fiscal 2023.
- Backlog increased to $29.1 billion, including $11.6 billion related directly or indirectly to the U.S. federal government. Approximately $9.8 billion, or 33.7% of total backlog, was expected to convert to revenue within the next fiscal year.
- Remaining performance obligations were approximately $18.7 billion, with 53% expected to be recognized within twelve months. Backlog and remaining performance obligations remain subject to cancellations, funding changes, scope changes and delays.
Guidance, Outlook, Management Commentary, Risks and Unusual Items
Management reported strong new prospects and sales and a positive outlook for many served industry groups and sectors. The filing does not provide a clear numeric fiscal 2024 revenue, earnings or cash-flow guidance value in the supplied text.
On November 20, 2023, after fiscal year-end, Jacobs entered into definitive agreements to spin off and combine CMS and the Cyber and Intelligence government-services portion of DVS with Amentum in a Reverse Morris Trust transaction intended to be tax-free to U.S. shareholders. Closing was expected in the second half of fiscal 2024, subject to regulatory approvals, an IRS private letter ruling, tax opinions and other conditions. Jacobs expected approximately $1.0 billion of cash at closing, subject to adjustments, and planned to use the proceeds to repay debt. Jacobs shareholders were expected to receive up to 51% of the combined company, while Jacobs expected to retain 7.5% to 12%, depending on fiscal 2024 operating-profit targets.
- Risks to the Amentum transaction include failure or delay to close, adverse regulatory or tax outcomes, inability to achieve operating targets, customer or employee disruption, stranded costs, transaction expenses and changes to Jacobs’ credit profile.
- Approximately 31% of fiscal 2023 revenue was earned directly or indirectly from U.S. federal agencies, exposing Jacobs to appropriations, shutdowns, audits, contract termination, recompete, suspension and debarment risks.
- Fixed-price contracts represented approximately 25.9% of revenue and expose the company to cost overruns, inflation, supply-chain disruption, labor costs and project delays. Cost-reimbursable contracts represented approximately 74.1%.
- Higher interest rates remain a material risk. A 1% increase in floating rates would have increased fiscal 2023 interest expense by approximately $22.4 million.
- Other principal risks include cybersecurity and privacy incidents, foreign-exchange volatility, geopolitical events, government funding reductions, competition, talent retention, litigation, environmental and nuclear liabilities, joint-venture exposures, insurance limitations and goodwill or intangible-asset impairment.
- Goodwill was $7.34 billion, representing approximately 50.2% of total assets. CMS and DVS passed quantitative impairment testing in fiscal 2023, and remaining reporting units had fair values materially above carrying values.
- Defined-benefit plans were underfunded by $61.5 million at year-end, down from $81.2 million. Estimated fiscal 2024 pension contributions were $19.3 million, primarily for non-U.S. plans.
- Management and Ernst & Young concluded that disclosure controls and internal control over financial reporting were effective. The audit opinion was unqualified. Critical audit matters involved revenue recognition for certain fixed-price contracts and valuation of PA Consulting redeemable noncontrolling interests.
Most Important Facts for Investors to Verify
- Confirm the timing, regulatory approvals, tax treatment, financing, cash proceeds and ownership percentages associated with the Amentum transaction.
- Reconcile reported backlog of $29.1 billion with remaining performance obligations of $18.7 billion and assess the effect of unfunded government awards, cancellations and scope changes.
- Review debt maturities, variable-rate exposure, covenant headroom and the planned use of transaction proceeds for debt repayment.
- Assess whether gross-margin pressure, PA Consulting utilization and restructuring charges improve or persist in fiscal 2024.
- Evaluate the sustainability of operating cash flow after working-capital benefits and the effect of share repurchases, dividends, capital expenditures and potential transaction costs.
- Review fixed-price project estimates, claims and change orders, government-contract audits, litigation reserves, insurance recoveries and nuclear-related indemnification.
- Monitor goodwill, PA Consulting redeemable noncontrolling interests and other valuation-sensitive balances for impairment or remeasurement risk.